Competitive disruption of COI1 receptor assembly by a hemibiotrophic bacterial effector suppresses jasmonate-mediated immunity
Proceedings of the National Academy of Sciences · 24.11.2026 · 123 (47)
DOI: 10.1073/pnas.2619743123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 17.11.2026. Verfasst von Peng Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Key Laboratory for Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, Shaanxi Normal Universi…. Hauptthemen laut MEDLINE: Cyclopentanes, Oxylipins, Ralstonia solanacearum, Arabidopsis Proteins. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities), | Natural Science Basic Research Program of Shaanxi Province ().
Abstract (Originalsprache)
Hormone pathways are central hubs in plant immunity, and their receptors, the critical initiators of signaling cascades, are logical targets of pathogen effectors. The jasmonic acid (JA) pathway is a cornerstone of defense against phytopathogens, especially necrotrophs. However, whether pathogens can directly target its receptor COI1 to subvert this defense layer has remained unclear. Here, we show that JA signaling positively regulates resistance to the devastating hemibiotrophic pathogen Ralstonia solanacearum and identified a bacterial effector, RipBO, that directly targets COI1 to counteract this defense. RipBO binds with high affinity to the F-box domain of COI1, competitively disrupts the COI1-ASK interaction, and thereby blocks SCF COI1 complex assembly. This disruption effectively stabilizes JAZ repressors and paralyzes JA-mediated immunity. Our findings clarify the contribution of JA signaling to bacterial wilt resistance and identify direct targeting of the hormone receptor as a pathogen virulence strategy, pointing to a potential vulnerability for crop protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Key Laboratory for Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, Shaanxi Normal University, Xi'an 710119, China.
- College of Plant Protection, State Key Laboratory of Agricultural and Forestry Biosecurity, Key Laboratory of Pest Monitoring and Green Management, Ministry of Agriculture and Rural Affairs, China Agricultural Universit…
ORCID-Profile: Peng Cao, Yuyan An, Meixiang Zhang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities)
- | Natural Science Basic Research Program of Shaanxi Province ()
- 陕西省科学技术厅 | Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Cao, P., An, Y., Li, X., Zhao, J., Zhang, X., Li, W., Gan, Y., Liu, J., & Zhang, M. (2026). Competitive disruption of COI1 receptor assembly by a hemibiotrophic bacterial effector suppresses jasmonate-mediated immunity. Proceedings of the National Academy of Sciences, 123(47). https://doi.org/10.1073/pnas.2619743123
Vancouver
Cao P, An Y, Li X, Zhao J, Zhang X, Li W, et al. Competitive disruption of COI1 receptor assembly by a hemibiotrophic bacterial effector suppresses jasmonate-mediated immunity. Proceedings of the National Academy of Sciences. 2026;123(47). doi:10.1073/pnas.2619743123
BibTeX
@article{Cao2026,
author = {Cao, Peng and An, Yuyan and Li, Xinjing and Zhao, Jiaoru and Zhang, Xi and Li, Wen and Gan, Yanling and Liu, Jun and Zhang, Meixiang},
title = {Competitive disruption of COI1 receptor assembly by a hemibiotrophic bacterial effector suppresses jasmonate-mediated immunity},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {47},
doi = {10.1073/pnas.2619743123}
}
EUVIMED